Journal of Clinical and Biomedical Sciences
Year: 2019, Volume: 9, Issue: 1, Pages: 3-9
Review Article
Rajeev Gandham1, Sumathi ME2*, Dayanand CD3 , Sheela SR4, Kiranmayee P5
1. PhD Scholar, Department of Biochemistry, Sri Devaraj Urs Medical College, Kolar.
2. Professor & HOD, Department of Biochemistry, Sri Devaraj Urs Medical College, Kolar.
3. Professor, Department of Biochemistry, Head of Allied Health Sciences, Sri Devaraj Urs Medical College.
4. Professor & HOD, Department of Obstetrics and Gynaecology ,Sri Devaraj Urs Medical College, Kolar.
5. Assistant Prof, Department of Cell Biology and Molecular Genetics, Sri Devaraj Urs Medical College, Kolar
*Corresponding Author
E-mail: [email protected]
Mobile No: 974371006
Background: Preeclampsia (PE) is a pregnancy specific disorder, characterized by new onset of hypertension and proteinuria after 20 weeks of gestation. It is one of the leading causes of maternal and perinatal morbidity and mortality. The etiology of the disease process in not known. There is an urgent need for a 1st trimester marker for the prediction of preeclampsia. Recent studies have reported that this disease originate from abnormal placentation and maternal endothelial dysfunction. The intense research in this arena has unveiled some important serum biomarkers which play an important role in placentation. These markers include angiogenic and antiangiogenic molecules. However, these markers when they used alone are not effective for the prediction of preeclampsia, but in combination may help in predicting women who are likely to develop preeclampsia. This review summarizes the various maternal serum biomarkers available and utility in predicting preeclampsia.
Keywords: Preeclampsia, Biomarkers, Angiogenic markers, Antiangiogenic markers, Apelin
Subscribe now for latest articles and news.
